Cerus Corporation (CERS) vs Evolus, Inc. (EOLS)
A side-by-side comparison of Cerus Corporation and Evolus, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CERS
Cerus Corporation
$2.36HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
EOLS
Evolus, Inc.
$7.41HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
Total return — CERS vs EOLS
growth of $100 · dividends reinvested · last 9yCERS -41.4% (-5.8%/yr)EOLS -35.0% (-4.7%/yr)EOLS compounded faster over this window
CERS EOLS
CERS vs EOLS: by the numbers
- •EOLS is the larger company ($488M vs $476M market cap).
- •Both run net losses; CERS's is the smaller (-3.06% vs -10.85% net margin).
- •EOLS grew revenue faster over the past five years (32.82% vs 15.74% CAGR).
Metrics side by side
Valuation
| Metric | CERS | EOLS |
|---|---|---|
| P/S ratio | 2.15 | 1.54 |
| P/B ratio | 6.79 | N/A |
| EV / EBITDA | 8097.24 | N/A |
Profitability
| Metric | CERS | EOLS |
|---|---|---|
| Gross margin | 52.05% | 66.25% |
| Operating margin | -0.73% | -7.33% |
| Net margin | -3.06% | -10.85% |
| ROE | -9.69% | N/A |
| ROIC | -1.08% | -15.54% |
Growth (annualized)
| Metric | CERS | EOLS |
|---|---|---|
| Revenue CAGR (5Y) | 15.74% | 32.82% |
| Total return CAGR (5Y) | -17.30% | 0.46% |
Frequently asked
- Which has grown faster, CERS or EOLS?
- Over the past five years, EOLS grew revenue faster — CERS at a 15.74% CAGR versus EOLS at 32.82%.
- How have CERS and EOLS total returns compared?
- Over the past 5 years, CERS delivered -17.30% and EOLS delivered 0.46% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cerus ROEEvolus ROECerus operating marginEvolus operating marginCerus revenue growthEvolus revenue growthCerus free cash flowEvolus free cash flow
Cerus & Evolus appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.